• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Microscopic submarines release drugs depending on acid concentration

January 25, 2017 By Sarah Faulkner

Microscopic submarines release drugs depending on acid concentrationResearchers have developed tiny ‘submarines’ that speed through the stomach using gastric acid for fuel. The proton-driven micromotors have a pH-sensitive polymer coating that can be loaded with drugs and released in the stomach.

Gastric acid can be destructive for orally-administered, pH-sensitive pharmaceuticals, including antibiotics. Although some coatings can protect substances from gastric acid, they can also prevent drugs from being activated in the stomach. Proton pump inhibitors, which block production of acid, can cause adverse side effects in patients if used for a long period of time.

A team of researchers have created micromotors that neutralize gastric acid and release its cargo when surrounding fluids reach a certain concentration of acid.

The team, led by Liangfang Zhang and Joseph Wang from the University of California, San Diego, published their work in the journal Angewandte Chemie. 

To construct the motors, researchers coated magnesium spheres with a nanolayer of gold and a pH-sensitive polymer, into which they embed a drug. A small spot on the magnesium core remains uncoated, facilitating an electrochemical reaction which consumes protons and forms magnesium ions. Tiny bubbles of hydrogen gas propel the motors, mixing liquid and speeding up the reaction.

Less than 20 minutes after the researchers administered the motors, the stomach environment reached a neutral pH, according to the team.

When the motors reach an environment with a neutral pH, the polymer dissolves and releases the payload. The motors also penetrate into the gastric mucosa, ultimately increasing the amount of time that the drug is retained in the stomach.

The researchers noted that the micromotors are biocompatible, safe to use, and that normal pH levels are re-established within 24 hours.

Filed Under: Featured, Pharmaceuticals, Research & Development Tagged With: University of California San Diego

IN CASE YOU MISSED IT

  • BD’s IV catheters plant in Utah marks 70 years
  • Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • Dexcom CFO to expand into COO role
  • Beta Bionics insulin patch pump scores FDA clearance

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS